ZXBio, Inc.
PrivateLast Round
Series A
Extension
Nov 6, 2024
Total Funding Raised
$2.17M
Company Overview
ZXBio, Inc. operates in Healthcare & Life Sciences and is based in Huzhou. Its latest recorded funding round was a Series A Extension round in November 2024.
ZXBio, Inc. is a biotechnology company that develops and produces monoclonal antibodies, antibody-based research and diagnostic reagents, and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZXBio, Inc. Comparables
Compare ZXBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Challen Biotechnology Co., Ltd. | 84% | |
| Zybio Inc. | 79% | |
| Elabscience Biotechnology Co.,Ltd | 78% |
For institutional investors. Book with your work email.
ZXBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 6, 2024 | ||||
| Series A Extension | Oct 7, 2023 | ||||
| Series A | Jun 9, 2022 | ||||
| Angel | Sep 1, 2020 | ||||
| Grant | Sep 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ZXBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huiyu Investment (Huizhi Group) | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2024
Huiyu Investment (Huizhi Group) participated in the round.
- Jun 9, 2022
Raised Series A round with Zhejiang Orient Gene Biotech Co Ltd.
For institutional investors. Book with your work email.
ZXBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ZXBio, Inc.'s valuation, stock price, and market status.
Is ZXBio, Inc. a public or private company?
ZXBio, Inc. is a private company.
What is the current stock price of ZXBio, Inc.?
ZXBio, Inc. is a private company, so its shares have no public market price. Caplight tracks ZXBio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ZXBio, Inc. worth (valuation)?
Valuation information for ZXBio, Inc. is not publicly available.
Can I buy ZXBio, Inc. stock?
ZXBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ZXBio, Inc.'s last funding round?
ZXBio, Inc.'s most recent funding round was Series A Extension on November 6, 2024.
Who are the main investors in ZXBio, Inc.?
Key investors in ZXBio, Inc. include Huiyu Investment (Huizhi Group).
Will ZXBio, Inc. IPO soon?
No public IPO plans have been announced for ZXBio, Inc..
How can I track ZXBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ZXBio, Inc.'s shares on secondary markets.